Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (53)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Goldman-Wohl, D. S.
Right arrow Articles by Yagel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldman-Wohl, D. S.
Right arrow Articles by Yagel, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 6, No. 1, 81-87, January 2000
© 2000 European Society of Human Reproduction and Embryology


Uterus and pregnancy

Tie-2 and angiopoietin-2 expression at the fetal–maternal interface: a receptor ligand model for vascular remodelling

Debra S. Goldman-Wohl1, Ilana Ariel2, Caryn Greenfield1, Yuval Lavy1 and Simcha Yagel1,3

1 Department of Obstetrics and Gynecology, and 2 Department of Pathology, Hadassah-University Hospital, Mt Scopus, POB 24035, Jerusalem 91240, Israel

Abstract

The blood vessels at the fetal–maternal interface widen dramatically during pregnancy in order to increase blood flow to nourish the developing fetus. This vessel remodelling destroys normal vessel integrity and encompasses the dissolution of vessel muscle and elastic tissue. It also includes the displacement of endothelial cells by fetal trophoblasts that invade the maternal arteries of the uterus. Interaction between the endothelial cell receptor, Tie-2, and its recently discovered antagonist ligand, angiopoietin-2 (Ang-2), has been implicated in the loosening of vessel structure. Using Northern blot hybridization and RNA in-situ hybridization analysis the expression pattern of Tie-2, and Ang-2 in the placenta throughout pregnancy, was investigated. We found Ang-2 expressed in the syncytiotrophoblast during the first trimester. In addition to the expected expression of the Tie-2 receptor in both fetal and maternal endothelial cells, we observed Tie-2 expression in endovascular invasive trophoblasts. These cells of epithelial origin invade the uterine spiral arteries and acquire endothelial cell properties. The temporal- and lineage-specific pattern of expression of Tie-2 and Ang-2 suggests that this receptor–ligand pair functions during the critical phase of development of the fetal vasculature and reworking of the maternal vessels during normal placentation.

angiopoietin-2/placenta/spiral artery/Tie-2/trophoblast

Notes

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
R. Ishimura, T. Kawakami, S. Ohsako, K. Nohara, and C. Tohyama
Suppressive Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Vascular Remodeling That Takes Place in the Normal Labyrinth Zone of Rat Placenta during Late Gestation
Toxicol. Sci., May 1, 2006; 91(1): 265 - 274.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
E. Geva, D.G. Ginzinger, D.H. Moore II, P.C. Ursell, and R.B. Jaffe
In utero angiopoietin-2 gene delivery remodels placental blood vessel phenotype: a murine model for studying placental angiogenesis
Mol. Hum. Reprod., April 1, 2005; 11(4): 253 - 260.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Geva, D. G. Ginzinger, C. J. Zaloudek, D. H. Moore, A. Byrne, and R. B. Jaffe
Human Placental Vascular Development: Vasculogenic and Angiogenic (Branching and Nonbranching) Transformation Is Regulated by Vascular Endothelial Growth Factor-A, Angiopoietin-1, and Angiopoietin-2
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4213 - 4224.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Wulff, H. Wilson, S. E. Dickson, S. J. Wiegand, and H. M. Fraser
Hemochorial Placentation in the Primate: Expression of Vascular Endothelial Growth Factor, Angiopoietins, and Their Receptors Throughout Pregnancy
Biol Reprod, March 1, 2002; 66(3): 802 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Ramsden, H. C. Cocks, M. Shams, S. Nijjar, J. C. Watkinson, M. C. Sheppard, A. Ahmed, and M. C. Eggo
Tie-2 Is Expressed on Thyroid Follicular Cells, Is Increased in Goiter, and Is Regulated by Thyrotropin through Cyclic Adenosine 3',5'-Monophosphate
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2709 - 2716.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. J. Currie, S. P. Gunningham, C. Han, P. A. E. Scott, B. A. Robinson, A. L. Harris, and S. B. Fox
Angiopoietin-1 Is Inversely Related to Thymidine Phosphorylase Expression in Human Breast Cancer, Indicating a Role in Vascular Remodeling
Clin. Cancer Res., April 1, 2001; 7(4): 918 - 927.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
L. P. Reynolds and D. A. Redmer
Angiogenesis in the Placenta
Biol Reprod, April 1, 2001; 64(4): 1033 - 1040.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. Pavelock, K. M. Braas, L'H. Ouafik, G. Osol, and V. May
Differential Expression and Regulation of the Vascular Endothelial Growth Factor Receptors Neuropilin-1 and Neuropilin-2 in Rat Uterus
Endocrinology, February 1, 2001; 142(2): 613 - 622.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. A. Ashkar, J. P. Di Santo, and B. A. Croy
Interferon {gamma} Contributes to Initiation of Uterine Vascular Modification, Decidual Integrity, and Uterine Natural Killer Cell Maturation during Normal Murine Pregnancy
J. Exp. Med., July 17, 2000; 192(2): 259 - 270.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.